Stocksigma LogoStocksigma Logo

Aarey Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 8,862 (+5.3% YoY | +98.6% QoQ) ■ EBITDA: 214 (-19.0% YoY | +61.6% QoQ) ■ EBITDA Margin (%): 2.4 (-72 bps YoY | -55 bps QoQ) ■ PAT: 137 (+33.8%

Aarey Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Aarey Drugs & Pharmaceuticals Ltd · Financial Result · 15 Nov 2026, 12:10 am

Aarey Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 8,862 (+5.3% YoY | +98.6% QoQ) ■ EBITDA: 214 (-19.0% YoY | +61.6% QoQ) ■ EBITDA Margin (%): 2.4 (-72 bps YoY | -55 bps QoQ) ■ PAT: 137 (+33.8% YoY | +33.8% QoQ) ■ EPS (INR): 0.43 (+19.4% YoY | +19.4% QoQ)

Original exchange filing (PDF)

More announcements from Aarey Drugs & Pharmaceuticals Ltd

All Aarey Drugs & Pharmaceuticals Ltd announcements